CLINICAL_TRIALS
trial_result
· 2017-10-31
Clinical Trial Update: Long-term Study of FK949E in Elderly Bipolar Disorder Patients [Phase 3]
Summary
Phase 3 long-term study of FK949E in elderly patients with bipolar disorder has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Astellas Pharma Inc | Conditions: Bipolar Disorder, Elderly | Phase 3 | Status: COMPLETED | Results posted: 2017-10-31